Stephen P. Squinto, EVP, Head of R&D at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,482 shares at $94.50 ($140K) on 2013-01-28, disclosed to the SEC on 2013-01-30.
Seasonal sale ($140k) by EVP, Head of R&D — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.50 | 715 | $68K | 48.3% |
| 2 | $94.32 | 767 | $72K | 51.7% |
| Total | $94.41 avg | 1,482 | $140K | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |